BOTHELL, Wash., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to restore neuronal health ...
来自MSN2 个月
Seattle biotech firm Athira Pharma will pay $4M to settle allegations related to research ...Athira raised $204 million in its IPO and was valued at around $670 million when it went public in 2020. The company’s market capitalization is now less than $25 million.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈